Albemarle Valuation
Is ALB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ALB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ALB * (MX$2051) is trading below our estimate of fair value (MX$9919)
Significantly Below Fair Value: ALB * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ALB *?
Other financial metrics that can be useful for relative valuation.
What is ALB *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$14.14b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | 19.6x |
PEG Ratio | 0.4x |
Price to Earnings Ratio vs Peers
How does ALB *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.3x | ||
CEMEX CPO CEMEX. de | 54.7x | 34.2% | Mex$196.6b |
PE&OLES * Industrias Peñoles. de | 39.5x | n/a | Mex$98.8b |
ICH B Industrias CH S. A. B. de C. V | 22.9x | n/a | Mex$75.6b |
GCC * GCC. de | 12.2x | 1.8% | Mex$64.6b |
ALB * Albemarle | 8.9x | 20.4% | Mex$14.1b |
Price-To-Earnings vs Peers: ALB * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the peer average (32.3x).
Price to Earnings Ratio vs Industry
How does ALB *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: ALB * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the Global Chemicals industry average (22.1x).
Price to Earnings Ratio vs Fair Ratio
What is ALB *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 9x |
Fair PE Ratio | 25.5x |
Price-To-Earnings vs Fair Ratio: ALB * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the estimated Fair Price-To-Earnings Ratio (25.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,051.00 | Mex$2,610.06 +27.3% | 24.1% | Mex$4,709.87 | Mex$1,387.27 | n/a | 27 |
Apr ’25 | Mex$2,125.00 | Mex$2,503.45 +17.8% | 25.1% | Mex$4,588.87 | Mex$1,351.63 | n/a | 27 |
Mar ’25 | Mex$2,421.71 | Mex$2,605.07 +7.6% | 26.6% | Mex$5,129.46 | Mex$1,538.84 | n/a | 27 |
Feb ’25 | Mex$1,943.42 | Mex$2,774.40 +42.8% | 25.2% | Mex$5,125.95 | Mex$1,537.79 | n/a | 27 |
Jan ’25 | Mex$2,505.00 | Mex$3,207.81 +28.1% | 30.3% | Mex$5,245.95 | Mex$1,532.91 | n/a | 27 |
Dec ’24 | Mex$2,109.40 | Mex$3,312.97 +57.1% | 30.2% | Mex$5,347.99 | Mex$1,562.72 | n/a | 27 |
Nov ’24 | Mex$2,195.00 | Mex$4,296.40 +95.7% | 23.5% | Mex$6,310.43 | Mex$2,794.62 | n/a | 26 |
Oct ’24 | Mex$3,000.39 | Mex$4,613.52 +53.8% | 17.8% | Mex$6,100.85 | Mex$2,701.81 | n/a | 24 |
Sep ’24 | Mex$3,423.00 | Mex$4,513.25 +31.9% | 18.3% | Mex$5,967.96 | Mex$2,642.95 | n/a | 25 |
Aug ’24 | Mex$3,595.00 | Mex$4,501.38 +25.2% | 19.9% | Mex$6,058.33 | Mex$2,608.45 | n/a | 25 |
Jul ’24 | Mex$3,960.00 | Mex$4,508.57 +13.9% | 20.6% | Mex$6,167.02 | Mex$2,655.24 | n/a | 25 |
Jun ’24 | Mex$3,440.00 | Mex$4,686.47 +36.2% | 21.9% | Mex$6,367.82 | Mex$2,741.70 | n/a | 24 |
May ’24 | Mex$3,228.00 | Mex$5,124.88 +58.8% | 25.2% | Mex$8,928.44 | Mex$2,778.93 | Mex$2,051.00 | 22 |
Apr ’24 | Mex$4,000.00 | Mex$5,818.11 +45.5% | 19.6% | Mex$9,076.75 | Mex$2,825.09 | Mex$2,125.00 | 22 |
Mar ’24 | Mex$4,578.00 | Mex$5,715.00 +24.8% | 19.3% | Mex$9,015.24 | Mex$2,805.95 | Mex$2,421.71 | 24 |
Feb ’24 | Mex$5,202.91 | Mex$5,895.52 +13.3% | 19.8% | Mex$9,358.26 | Mex$2,918.57 | Mex$1,943.42 | 23 |
Jan ’24 | Mex$4,230.00 | Mex$6,083.79 +43.8% | 19.5% | Mex$8,926.11 | Mex$3,001.19 | Mex$2,505.00 | 21 |
Dec ’23 | Mex$5,195.00 | Mex$6,202.27 +19.4% | 19.5% | Mex$8,903.15 | Mex$2,993.47 | Mex$2,109.40 | 20 |
Nov ’23 | Mex$5,560.00 | Mex$6,279.72 +12.9% | 20.1% | Mex$8,823.50 | Mex$2,907.74 | Mex$2,195.00 | 20 |
Oct ’23 | Mex$5,515.00 | Mex$6,239.93 +13.1% | 21.1% | Mex$8,975.38 | Mex$2,957.80 | Mex$3,000.39 | 20 |
Sep ’23 | Mex$5,150.00 | Mex$5,953.89 +15.6% | 21.0% | Mex$8,801.32 | Mex$2,900.44 | Mex$3,423.00 | 20 |
Aug ’23 | Mex$4,597.00 | Mex$5,684.79 +23.7% | 20.0% | Mex$7,492.85 | Mex$2,748.74 | Mex$3,595.00 | 20 |
Jul ’23 | Mex$4,477.78 | Mex$5,582.69 +24.7% | 19.5% | Mex$7,336.01 | Mex$2,691.20 | Mex$3,960.00 | 21 |
Jun ’23 | Mex$4,715.01 | Mex$5,547.98 +17.7% | 17.6% | Mex$7,213.06 | Mex$2,646.09 | Mex$3,440.00 | 20 |
May ’23 | Mex$4,000.00 | Mex$5,015.56 +25.4% | 20.4% | Mex$6,217.55 | Mex$1,620.21 | Mex$3,228.00 | 20 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.